Cargando…

Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study

PURPOSE: Although immune dysfunction has been investigated in adult septic patients, early immune status remains unclear. In this study, our primary aim was to assess early immune status in adult patients with sepsis stratified by age and its relevance to hospital mortality. PATIENTS AND METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei, Fei, Zhang, Guan-Rong, Zhou, Li-Xin, Liu, Ji-Yun, Ma, Gang, Kou, Qiu-Ye, He, Zhi-Jie, Chen, Min-Ying, Nie, Yao, Wu, Jian-Feng, Guan, Xiang-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335299/
https://www.ncbi.nlm.nih.gov/pubmed/32636658
http://dx.doi.org/10.2147/IDR.S246513
_version_ 1783554116783439872
author Pei, Fei
Zhang, Guan-Rong
Zhou, Li-Xin
Liu, Ji-Yun
Ma, Gang
Kou, Qiu-Ye
He, Zhi-Jie
Chen, Min-Ying
Nie, Yao
Wu, Jian-Feng
Guan, Xiang-Dong
author_facet Pei, Fei
Zhang, Guan-Rong
Zhou, Li-Xin
Liu, Ji-Yun
Ma, Gang
Kou, Qiu-Ye
He, Zhi-Jie
Chen, Min-Ying
Nie, Yao
Wu, Jian-Feng
Guan, Xiang-Dong
author_sort Pei, Fei
collection PubMed
description PURPOSE: Although immune dysfunction has been investigated in adult septic patients, early immune status remains unclear. In this study, our primary aim was to assess early immune status in adult patients with sepsis stratified by age and its relevance to hospital mortality. PATIENTS AND METHODS: A post hoc analysis of a multicenter, randomized controlled trial was conducted; 273 patients whose immune status was evaluated within 48 hours after onset of sepsis were enrolled. Early immune status was evaluated by the percentage of monocyte human leukocyte antigen-DR (mHLA-DR) in total monocytes within 48 hours after onset of sepsis and it was classified as immunoparalysis (mHLA-DR ≤30%) or non-immunoparalysis (>30%). Three logistic regression models were conducted to explore the associations between early immunoparalysis and hospital mortality. We also developed two sensitivity analyses to find out whether the definition of early immune status (24 hours vs 48 hours after onset of sepsis) and immunotherapy affect the primary outcome. RESULTS: Of the 181 elderly (≥60yrs) and 92 non-elderly (<60yrs) septic patients, 71 (39.2%) and 25 (27.2%) died in hospital, respectively. The percentage of early immunoparalysis in the elderly was twice of that in the non-elderly patients (32% vs 16%, p=0.006). For the elderly, hospital mortality was higher in the immunoparalysis ones than the non-immunoparalysis ones (53.4% vs 32.5%, p=0.009). But there was no significant difference in hospital mortality between immunoparalysis non-elderly patients and non-immunoparalysis non-elderly ones (33.5% vs 26.0%, p=0.541). By means of logistic regression models, we found that early immunoparalysis was independently associated with increased hospital mortality in elderly, but not in non-elderly patients. Sensitivity analysis further confirmed the definition of early immune status and immunotherapy did not affect the outcomes. CONCLUSION: The elderly were more susceptible to early immunoparalysis after onset of sepsis. Early immunoparalysis was independently associated with poor prognosis in elderly, but not in non-elderly patients.
format Online
Article
Text
id pubmed-7335299
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73352992020-07-06 Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study Pei, Fei Zhang, Guan-Rong Zhou, Li-Xin Liu, Ji-Yun Ma, Gang Kou, Qiu-Ye He, Zhi-Jie Chen, Min-Ying Nie, Yao Wu, Jian-Feng Guan, Xiang-Dong Infect Drug Resist Original Research PURPOSE: Although immune dysfunction has been investigated in adult septic patients, early immune status remains unclear. In this study, our primary aim was to assess early immune status in adult patients with sepsis stratified by age and its relevance to hospital mortality. PATIENTS AND METHODS: A post hoc analysis of a multicenter, randomized controlled trial was conducted; 273 patients whose immune status was evaluated within 48 hours after onset of sepsis were enrolled. Early immune status was evaluated by the percentage of monocyte human leukocyte antigen-DR (mHLA-DR) in total monocytes within 48 hours after onset of sepsis and it was classified as immunoparalysis (mHLA-DR ≤30%) or non-immunoparalysis (>30%). Three logistic regression models were conducted to explore the associations between early immunoparalysis and hospital mortality. We also developed two sensitivity analyses to find out whether the definition of early immune status (24 hours vs 48 hours after onset of sepsis) and immunotherapy affect the primary outcome. RESULTS: Of the 181 elderly (≥60yrs) and 92 non-elderly (<60yrs) septic patients, 71 (39.2%) and 25 (27.2%) died in hospital, respectively. The percentage of early immunoparalysis in the elderly was twice of that in the non-elderly patients (32% vs 16%, p=0.006). For the elderly, hospital mortality was higher in the immunoparalysis ones than the non-immunoparalysis ones (53.4% vs 32.5%, p=0.009). But there was no significant difference in hospital mortality between immunoparalysis non-elderly patients and non-immunoparalysis non-elderly ones (33.5% vs 26.0%, p=0.541). By means of logistic regression models, we found that early immunoparalysis was independently associated with increased hospital mortality in elderly, but not in non-elderly patients. Sensitivity analysis further confirmed the definition of early immune status and immunotherapy did not affect the outcomes. CONCLUSION: The elderly were more susceptible to early immunoparalysis after onset of sepsis. Early immunoparalysis was independently associated with poor prognosis in elderly, but not in non-elderly patients. Dove 2020-06-30 /pmc/articles/PMC7335299/ /pubmed/32636658 http://dx.doi.org/10.2147/IDR.S246513 Text en © 2020 Pei et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Pei, Fei
Zhang, Guan-Rong
Zhou, Li-Xin
Liu, Ji-Yun
Ma, Gang
Kou, Qiu-Ye
He, Zhi-Jie
Chen, Min-Ying
Nie, Yao
Wu, Jian-Feng
Guan, Xiang-Dong
Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study
title Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study
title_full Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study
title_fullStr Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study
title_full_unstemmed Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study
title_short Early Immunoparalysis Was Associated with Poor Prognosis in Elderly Patients with Sepsis: Secondary Analysis of the ETASS Study
title_sort early immunoparalysis was associated with poor prognosis in elderly patients with sepsis: secondary analysis of the etass study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335299/
https://www.ncbi.nlm.nih.gov/pubmed/32636658
http://dx.doi.org/10.2147/IDR.S246513
work_keys_str_mv AT peifei earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT zhangguanrong earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT zhoulixin earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT liujiyun earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT magang earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT kouqiuye earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT hezhijie earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT chenminying earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT nieyao earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT wujianfeng earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT guanxiangdong earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy
AT earlyimmunoparalysiswasassociatedwithpoorprognosisinelderlypatientswithsepsissecondaryanalysisoftheetassstudy